T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis

摘要

We compared the survival outcomes of breast-conserving therapy (BCT) and mastectomy in patients with T1-2N0M0 triple-negative breast cancer (TNBC). An analysis of 14,910 patients demonstrated better overall survival and cause-specific survival in patients with BCT, suggesting that BCT could be an appropriate option for T1-2N0M0 TNBC. Further prospective studies are needed to confirm these conclusions.